Statistics about Health, Pharma & Medtech in Worldwide
Statistics
- Global next-generation biomanufacturing market size 2020 & 2031
- Global cell and gene therapy manufacturing market forecast 2023-2033
- Biomarker technologies: global market forecast 2024 and 2029
- Global cancer immunotherapy market size 2023 and 2032 forecast
- Global next-generation biomanufacturing market share by workflow 2020 & 2031
- Global epigenetics market size 2020 vs. 2031 projection
- Global epigenetics market share by application 2020 vs. 2031
- CRISPR gene editing market share globally by application 2020-2031
- Share of cell therapy studies being conducted globally as of 2018, by region
- R&D expenses of BioNTech 2017-2023
- R&D expenses of BioNTech by type 2022-2023
- Moderna net income 2016-2023
- AbbVie's key product revenues 2022-2023
- Revenue forecast of AbbVie's Humira 2018-2024
- Top select autoimmune drugs worldwide 2023
- Pfizer's top products based on revenue 2023
- Leading global vaccine products by revenue 2022
- Revenue of Perjeta 2018-2022
- Merck & Co.'s Keytruda revenue 2014-2023
- Moderna's revenue 2016-2023
- Moderna total assets 2016-2023
- R&D expenses of Moderna 2016-2023
- Revenue of AbbVie's Humira 2011-2023
- Moderna Inc collaboration revenue by related party 2018-2023
- R&D expenses of Moderna by type 2023
- Sanofi: human vaccine revenues 2023
- Eli Lilly and Company's top products based on revenue 2022-2023
- Trust levels towards biotech/life sciences by country 2021
- Leading mRNA biotech companies' market cap 2023
- Leading mRNA biotech companies' revenues 2022
- Leading mRNA biotech companies' net income 2022
- Leading mRNA biotech companies' R&D spending 2022
- Select country share in biotechnology patents 2020
- Number of employees at AbbVie 2013-2024
- Amgen's operating expenses 2009-2023
- Biotechnology R&D expenditure in selected countries 2021
- Preclinical programs for antibacterial agents worldwide by mode of action 2021
- Novo Nordisk sales of leading products 2023
- Major biotech IPOs 2023
- Global cell culture market size 2022-2030
- Number of gene therapies quarterly by phase 2021-2023
- Number of gene therapies in pipeline by therapy area Q3 2023
- Share of global RNA therapy pipeline Q3 2023, by phase
- Top global biotech companies - net sales 2022
- Top global biotech companies based on number of employees 2023
- Non-traditional antibacterials in clinical pipeline globally by type 2021
- Preclinical antibacterial products worldwide targeting priority pathogens 2021
- Antibacterial agents in preclinical programs worldwide by type 2021
- Amgen's expenditure on research and development by category 2012-2023
- Developers with antibacterials in preclinical pipeline by type 2021
- Top drugs based on projected 2024 global sales
- Projected most valuable R&D projects based on net present value 2023
- Amgen earnings per share 2004-2023
- Amgen's total revenue 2004-2023
- Amgen's expenditure on research and development 2006-2023
- Amgen's cash flow 2004-2023
- Amgen's total revenues in the U.S. and abroad 2006-2023
- Amgen's net income 2009-2023
- Amgen's total assets 2009-2023
- Biotechnology R&D intensity in enterprise sector by country 2021
- Biotechnology R&D expenditure as percent of BERD in select countries 2021
- Commercial revenues of BioNTech by type 2023
- Distribution of active mRNA clinical trials worldwide 2022, by disease
- Global mRNA vaccine and therapy market value by disease 2020-2030
- mRNA vaccine and therapy market value by world region 2020-2030
- mRNA vaccine and therapy market value worldwide 2020-2030
- Key indications in the oncology pipeline worldwide 2021
- Orphan and non-orphan drugs in the pipeline worldwide 2021
- Global gene cloning services market 2020-2031
- Global gene cloning services market share by type 2020-2031
- Number of active trials for cell and gene therapies worldwide 2022 by trial phase
- Indications in clinical trials for cell and gene therapies worldwide 2022
- Number of active trials for cell and gene therapies 2022, by region
- Cell therapy companies investment 2017-2021
- Value share of biotech sector worldwide by therapeutic area 2021
- Number of cellular immunotherapy pipeline globally by type 2020-2021
- Gene, cell, and RNA therapy startup financing quarterly 2022
- Number of gene, cell, and RNA therapy deals quarterly by type 2022
- Revenue of BioNTech 2017-2023
- Operating income of BioNTech 2017-2023
- Earnings per share of BioNTech 2017-2023
- Number of shares of BioNTech 2017-2023
- Total assets of BioNTech 2017-2023
- Number of acquisition deals in biopharma industry 2017-2021, by therapy focus
- Profit of BioNTech 2017-2023
- Value share of biotech sector worldwide 2021, by country
- Value of biotech sector worldwide 2021, by therapeutic area
- Revenue of leading public synthetic biology companies worldwide 2022
- MorphoSys' research & development expenditure 2006-2023
- Global active regenerative medicine clinical trials by indication 2023
- Global active regenerative medicine clinical trials by approach 2023
- Global active regenerative medicine clinical trials by region 2023
- Global ongoing regenerative medicine clinical trials by phase and sponsor 2023
- Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021
- Top global pharma companies by immunology revenue 2022
- Qiagen revenue 2012-2023
- Qiagen net income 2012-2023
- Qiagen R&D spending 2012-2023
- MorphoSys' revenue 2006-2023
- COVID-19 vaccine dose numbers by top manufacturer 2021